Michael Crowley - 28 Nov 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, GBL Commercial Operations
Signature: /s/ Michael Crowley
Issuer symbol: BIO
Transactions as of: 28 Nov 2023
Net transactions value: -$195,874
Form type: 4
Filing time: 28 Nov 2023, 17:48:33 UTC
Previous filing: 06 Sep 2023
Next filing: 28 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO BIOB	Bio-Rad A Common Stock	Sale	$195,874	-642	-8.5%	$305.10	6,942	28 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.05 to $305.13, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.05 to $305.13, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.